Medication Access and Training Expansion Act of 2021 or the MATE Act of 2021
This bill requires health care providers, as a condition of receiving or renewing a registration to prescribe potentially addictive drugs, to complete a one-time training on managing patients with substance use disorders.
In addition, the Department of Health and Human Services must award grants to health professional associations and education programs for integrating substance use disorder training into relevant curricula.
[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2067 Introduced in House (IH)]
<DOC>
117th CONGRESS
1st Session
H. R. 2067
To amend the Controlled Substances Act to require physicians and other
prescribers of controlled substances to complete training on treating
and managing patients with opioid and other substance use disorders,
and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 18, 2021
Mrs. Trahan (for herself, Mr. Carter of Georgia, Mr. McKinley, Ms.
Kuster, Mr. Trone, and Mr. Tonko) introduced the following bill; which
was referred to the Committee on Energy and Commerce, and in addition
to the Committee on the Judiciary, for a period to be subsequently
determined by the Speaker, in each case for consideration of such
provisions as fall within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To amend the Controlled Substances Act to require physicians and other
prescribers of controlled substances to complete training on treating
and managing patients with opioid and other substance use disorders,
and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Medication Access and Training
Expansion Act of 2021'' or the ``MATE Act of 2021''.
SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUBSTANCES TO COMPLETE
TRAINING ON TREATING AND MANAGING PATIENTS WITH OPIOID
AND OTHER SUBSTANCE USE DISORDERS.
Section 303 of the Controlled Substances Act (21 U.S.C. 823) is
amended by adding at the end the following:
``(l) Required Training for Prescribers on Treating and Managing
Patients With Opioid and Other Substance Use Disorders.--
``(1) Applicability.--This subsection applies--
``(A) with respect to any practitioner who is
licensed under State law to prescribe controlled
substances and is not a veterinarian or a dentist; and
``(B) beginning with the first registration or
renewal of registration by the practitioner under this
section occurring 180 or more days after the date of
enactment of the Medication Access and Training
Expansion Act of 2021.
``(2) Training required.--As a condition on registration
under this section to dispense controlled substances in
schedule II, III, IV, or V, the Attorney General shall require
any practitioner described in paragraph (1)(A) to meet the
following:
``(A) If the practitioner is a physician, the
practitioner must meet one or more of the following
conditions:
``(i) The physician holds a board
certification in addiction psychiatry or
addiction medicine from the American Board of
Medical Specialties.
``(ii) The physician holds a board
certification from the American Board of
Addiction Medicine.
``(iii) The physician holds a board
certification in addiction medicine from the
American Osteopathic Association.
``(iv) The physician has, with respect to
the treatment and management of patients with
opioid or other substance use disorders,
completed not less than 8 hours of training
(through classroom situations, seminars at
professional society meetings, electronic
communications, or otherwise) that is provided
by--
``(I) the American Society of
Addiction Medicine, the American
Academy of Addiction Psychiatry, the
American Medical Association, the
American Osteopathic Association, the
American Psychiatric Association, or
any other organization accredited by
the Accreditation Council for
Continuing Medical Education (commonly
known as the `ACCME');
``(II) any organization accredited
by a State medical society accreditor
recognized by the ACCME; or
``(III) any organization accredited
by the American Osteopathic Association
to provide continuing medical
education.
``(v) The physician graduated in good
standing from an accredited school of
allopathic medicine or osteopathic medicine in
the United States during the 5-year period
immediately preceding the date on which the
physician first registers or renews under this
section and has successfully completed a
comprehensive allopathic or osteopathic
medicine curriculum or accredited medical
residency that included not less than 8 hours
of training on treating and managing patients
with opioid and other substance use disorders,
including the appropriate clinical use of all
drugs approved by the Food and Drug
Administration for the treatment of a substance
use disorder.
``(B) If the practitioner is not a physician, the
practitioner must meet one or more of the following
conditions:
``(i) Completed not fewer than 8 hours of
training with respect to the treatment and
management of patients with opioid or other
substance use disorders (through classroom
situations, seminars at professional society
meetings, electronic communications, or
otherwise) provided by the American Society of
Addiction Medicine, the American Academy of
Addiction Psychiatry, the American Medical
Association, the American Osteopathic
Association, the American Nurses Credentialing
Center, the American Psychiatric Association,
the American Association of Nurse
Practitioners, the American Academy of
Physician Assistants, or any other organization
that the Secretary determines is appropriate
for purposes of this clause.
``(ii) Graduated in good standing from an
accredited physician assistant school or
accredited school of advanced practice nursing
in the United States during the 5-year period
immediately preceding the date on which the
practitioner first registers or renews under
this section and has successfully completed a
comprehensive physician assistant or advanced
practice nursing curriculum that included not
less than 8 hours of training on treating and
managing patients with opioid and other
substance use disorders, including the
appropriate clinical use of all drugs approved
by the Food and Drug Administration for the
treatment of a substance use disorder.
``(3) One-time training.--The Attorney General shall not
require any practitioner to complete the training described in
clause (iv) or (v) of paragraph (2)(A) or clause (i) or (ii) of
paragraph (2)(B) more than once.
``(4) Rule of construction.--Nothing in this subsection
shall be construed to prevent a practitioner from using the
same training both for purposes of satisfying the registration
requirement of this subsection and for other purposes, such as
satisfying State licensing requirements.''.
SEC. 3. PRACTITIONER EDUCATION GRANT PROGRAM.
Title V of the Public Health Service Act is amended by inserting
after section 509 of such Act (42 U.S.C. 290bb-2) the following:
``SEC. 510. PRACTITIONER EDUCATION GRANT PROGRAM.
``(a) In General.--The Secretary shall carry out a program to award
grants to eligible entities to expand the integration of substance use
disorder education into the standard curriculum of relevant health care
and health services education programs, thereby expanding the number of
practitioners who deliver high-quality, evidence-based substance use
disorder treatment.
``(b) Eligible Entities.--To be eligible to receive a grant under
this section, an entity shall be--
``(1) a private nonprofit or public professional
association representing health care professionals in the field
of medicine, physician assistants, nursing, social work,
psychology, marriage and family therapy, or health services
administration; or
``(2) a private nonprofit or public entity that is a
university, college, or other professional school.
``(c) Authorization of Appropriations.--To carry out this section,
there is authorized to be appropriated such sums as may be necessary
for each of fiscal years 2022 through 2027.''.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line